Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global VariZIG Market Report 2025

VariZIG Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Patient Condition (Immunocompromised Patients, Pregnant Women), By Distribution Channel (Hospitals, Pharmacies, Healthcare Providers), By End User (Adult, Geriatric, Pediatric)

VariZIG Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
VariZIG Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

What Is Covered Under VariZIG Market?

VariZIG is a hyperimmune globulin derived from human plasma with high antibodies against the varicella-zoster virus (VZV). It is used as a post-exposure prophylaxis to reduce the severity of chickenpox in high-risk individuals, such as immunocompromised patients, pregnant women, and newborns. Administered intramuscularly, it provides passive immunity by delivering pre-formed antibodies. Varizig is most effective when given within 96 hours of VZV exposure.

The main patient conditions for varizig are immunocompromised patients and pregnant women. Immunocompromised patients have weakened immune systems due to conditions such as HIV, cancer treatments, or immunosuppressive therapy. These are distributed through various distribution channels such as hospitals, pharmacies, and healthcare providers and are used by various end users such as adults, geriatric, and pediatric populations.

What Is The VariZIG Market Size 2025 And Growth Rate?

The varizig market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to growth in healthcare expenditure, growth in the prevalence of organ transplantation procedures, rise in government funding for immunization programs, growth in the geriatric population, and growth in private insurance coverage.

What Is The VariZIG Market Growth Forecast?

The varizig market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing incidence of chickenpox, rising investments in the development of varicella-related biologics, growing demand for immune globulin products, increasing public health initiatives, and rising clinical trials. Major trends in the forecast period include technological advancements, adoption in global humanitarian, advancements in recombinant DNA technology, development of novel formulations, and telemedicine.

VariZIG Market Size and growth rate 2025 to 2029: Graph

How Is The VariZIG Market Segmented?

The varizig market covered in this report is segmented –

1) By Patient Condition: Immunocompromised Patients; Pregnant Women

2) By Distribution Channel: Hospitals; Pharmacies; Healthcare Providers

3) By End User: Adult; Geriatric; Pediatric

Book your 30 minutes free consultation with our research experts

Contact Us

What Is Driving The VariZIG Market? Rising Incidence Of Varicella-Zoster Virus Infections Drives Demand For In High-Risk Populations

The increase in the incidence of varicella-zoster virus infections is expected to drive the varizig market going forward. The varicella-zoster virus (VZV) is a highly contagious virus that causes chickenpox as the primary infection and can reactivate later in life to cause shingles (herpes zoster). The increase in the incidence of varicella-zoster virus (VZV) infections, leading to conditions such as chickenpox and shingles, can be attributed to reduced vaccination rates, an aging population, and immune suppression due to medical treatments. varizig helps varicella-zoster virus patients by providing passive immunity, reducing the severity and duration of chickenpox symptoms, preventing complications in high-risk individuals such as immunocompromised patients, and offering protection against severe outcomes in neonates and pregnant women exposed to the virus. For instance, in November 2024, according to the Florida Department of Health, a US-based government agency, in 2023, the number of varicella cases increased to 653, compared to 428 cases in 2022. Therefore, the rising incidence of varicella-zoster virus infections drives the varizig market.

What Is Driving The VariZIG Market? Impact Of Rising Healthcare Spending On The Market

The rise in healthcare spending is expected to propel the growth of the varizig market going forward. Healthcare spending refers to the total expenditure on health services and products, including medical care, hospital services, preventive care, medications, research, infrastructure, and administrative costs, to maintain or improve the health and well-being of individuals and populations. Healthcare spending is attributed to an aging population, advancements in medical technology, rising prevalence of chronic diseases, and increased demand for healthcare services. Healthcare expenditure supports varizig by allocating funding for the acquisition and distribution of this essential immune globulin, ensuring its availability to high-risk populations, enabling healthcare providers to offer timely treatment for varicella-zoster virus infections, and helping to reduce the overall healthcare burden associated with severe complications from the virus. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure in UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Therefore, the rise in healthcare spending is driving the growth of the varizig market.

Who Are The Major Players In The Global VariZIG Market?

Major companies operating in the varizig market are Emergent BioSolutions Inc.

What Are The Key Trends Of The Global VariZIG Market? Strategic Agreement To Gain Competitive Advantage In The Market

The key trend in the varizig market is securing supply agreements to the product for high-risk patient populations, expanding distribution channels, and meeting the growing demand for passive immunization, particularly in emergency and high-exposure scenarios. Supply agreements are contracts between parties that outline the terms and conditions for providing goods or services, including pricing, delivery schedules, and responsibilities of each party. For instance, in July 2022, Kamada Ltd., an Israel-based biopharmaceutical company, announced an $11.4 million procurement agreement to supply its product VARIZIG to an undisclosed international organization primarily operating in Latin America. The supply is expected to take place from the fourth quarter of 2022 through the first half of 2023. This agreement reflects Kamada's strategy to expand its sales of FDA-approved plasma-derived therapies in international markets, highlighting the commercial potential beyond North America. VARIZIG is specifically indicated for post-exposure prophylaxis of varicella (chickenpox) in high-risk groups, such as immunocompromised patients and newborns, making it a crucial therapeutic option for these populations.

Regional Analysis For The Global VariZIG Market

North America was the largest region in the varizig market in 2024. The regions covered in the varizig market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the varizig market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the VariZIG Market?

The varizig market consists of sales of pre-filled syringes, injectable solutions, and single-dose vials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the VariZIG Industry?

The varizig market research report is one of a series of new reports from The Business Research Company that provides varizig market statistics, including varizig industry global market size, regional shares, competitors with a varizig market share, detailed varizig market segments, market trends and opportunities, and any further data you may need to thrive in the varizig industry. This varizig market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

VariZIG Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The varizig market covered in this report is segmented –
1) By Patient Condition: Immunocompromised Patients; Pregnant Women
2) By Distribution Channel: Hospitals; Pharmacies; Healthcare Providers
3) By End User: Adult; Geriatric; Pediatric
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Emergent BioSolutions Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. VariZIG Market Characteristics

    3. VariZIG Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. VariZIG Market Trends And Strategies

    5. VariZIG Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global VariZIG Growth Analysis And Strategic Analysis Framework

    6.1. Global VariZIG PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global VariZIG Market Growth Rate Analysis

    6.4. Global VariZIG Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global VariZIG Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global VariZIG Total Addressable Market (TAM)

    7. Global VariZIG Pricing Analysis & Forecasts

    8. VariZIG Market Segmentation

    8.1. Global VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Immunocompromised Patients

    Pregnant Women

    8.2. Global VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals

    Pharmacies

    Healthcare Providers

    8.3. Global VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Adult

    Geriatric

    Pediatric

    9. Global VariZIG Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. VariZIG Market Regional And Country Analysis

    10.1. Global VariZIG Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global VariZIG Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific VariZIG Market

    11.1. Asia-Pacific VariZIG Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China VariZIG Market

    12.1. China VariZIG Market Overview

    12.2. China VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India VariZIG Market

    13.1. India VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan VariZIG Market

    14.1. Japan VariZIG Market Overview

    14.2. Japan VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia VariZIG Market

    15.1. Australia VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea VariZIG Market

    16.1. South Korea VariZIG Market Overview

    16.2. South Korea VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe VariZIG Market

    17.1. Western Europe VariZIG Market Overview

    17.2. Western Europe VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK VariZIG Market

    18.1. UK VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany VariZIG Market

    19.1. Germany VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France VariZIG Market

    20.1. France VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe VariZIG Market

    21.1. Eastern Europe VariZIG Market Overview

    21.2. Eastern Europe VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America VariZIG Market

    22.1. North America VariZIG Market Overview

    22.2. North America VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA VariZIG Market

    23.1. USA VariZIG Market Overview

    23.2. USA VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada VariZIG Market

    24.1. Canada VariZIG Market Overview

    24.2. Canada VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America VariZIG Market

    25.1. South America VariZIG Market Overview

    25.2. South America VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East VariZIG Market

    26.1. Middle East VariZIG Market Overview

    26.2. Middle East VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa VariZIG Market

    27.1. Africa VariZIG Market Overview

    27.2. Africa VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. VariZIG Market Competitive Landscape And Company Profiles

    28.1. VariZIG Market Competitive Landscape

    28.2. VariZIG Market Company Profiles

    28.2.1. Emergent BioSolutions Inc. Overview, Products and Services, Strategy and Financial Analysis

    29. Global VariZIG Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global VariZIG Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The VariZIG Market

    32. Recent Developments In The VariZIG Market

    33. VariZIG Market High Potential Countries, Segments and Strategies

    33.1 VariZIG Market In 2029 - Countries Offering Most New Opportunities

    33.2 VariZIG Market In 2029 - Segments Offering Most New Opportunities

    33.3 VariZIG Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global VariZIG Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global VariZIG Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Emergent BioSolutions Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global VariZIG Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global VariZIG Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, VariZIG Market, Segmentation By Patient Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, VariZIG Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, VariZIG Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Emergent BioSolutions Inc. Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Read More

What Is The Compression Therapy Market Overview In 2022?

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the stem cell therapy market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the regenerative medicine for cartilage market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the covid-19 current therapy market research report 2022 with industry size, share, segments and market growth

Read More

Porcine Plasma Feed Market 2023 – By Type (Powder, Grain, Other Types), By Application (Swine Feed, Pet Food, Aquafeed, Other Applications), By End User (Farmers, Farming Organizations, Feed Additive Companies, Animal Feed For Pets), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Plasma Feed Global Market Report 2025 – By Source (Porcine, Bovine, Other Sources), By Sales Channel (Online, Offline), By Application (Swine Feed, Pet Food, Aquafeed, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Blood Plasma Derivatives Global Market Report 2025 – By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types), By Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, Other Applications), By End-User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Plasma Powder Global Market Report 2025 – By Source (Bovine, Porcine, Ovine, Other Sources), By Form (Dry, Wet), By Sales Channel (Online, Offline), By Application (Pet Food, Pig Feed, Poultry Feed, Aqua Feed, Ruminant Feed, Human Food, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cold Plasma Global Market Report 2025 – By Regime (Atmospheric Cold Plasma, Low-Pressure Cold Plasma ), By Technology (Remote Treatment, Direct Treatment, Electrode Contact ), By Application (Wound Healing, Blood Coagulation, Dentistry, Cancer Treatment, Other Medical Applications), By End Use Sector (Automotive, Electronics & Semiconductors, Food Processing & Packaging, Medical, Aerospace, Polymers & Plastics, Other End-User Sector) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Porcine Plasma Feed Global Market Report 2025 – By Type (Powder, Grain, Other Types), By Application (Swine Feed, Pet Food, Aquafeed, Other Applications), By End User (Farmers, Farming Organizations, Feed Additive Companies, Animal Feed For Pets) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Plasma Fractionation Global Market Report 2025 – By Product (Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors), By Application (Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology), By End User (Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Plasma Protein Therapeutics Global Market Report 2025 – By Product (Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products), By Route Of Administration (Intravenous, Subcutaneous), By Applications (Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the VariZIG market?

VariZIG is a hyperimmune globulin derived from human plasma with high antibodies against the varicella-zoster virus (VZV). It is used as a post-exposure prophylaxis to reduce the severity of chickenpox in high-risk individuals, such as immunocompromised patients, pregnant women, and newborns. Administered intramuscularly, it provides passive immunity by delivering pre-formed antibodies. Varizig is most effective when given within 96 hours of VZV exposure. For further insights on the VariZIG market, request a sample here

How will the VariZIG market drivers and restraints affect the market dynamics? What forces will shape the VariZIG industry going forward?

The VariZIG market major growth driver - Rising Incidence Of Varicella-Zoster Virus Infections Drives Demand For In High-Risk Populations. For further insights on the VariZIG market, request a sample here

What is the forecast market size or the forecast market value of the VariZIG market?

The VariZIG market size has grown strongly in recent years. The varizig market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to growth in healthcare expenditure, growth in the prevalence of organ transplantation procedures, rise in government funding for immunization programs, growth in the geriatric population, and growth in private insurance coverage. The varizig market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing incidence of chickenpox, rising investments in the development of varicella-related biologics, growing demand for immune globulin products, increasing public health initiatives, and rising clinical trials. Major trends in the forecast period include technological advancements, adoption in global humanitarian, advancements in recombinant DNA technology, development of novel formulations, and telemedicine. For further insights on the VariZIG market, request a sample here

How is the VariZIG market segmented?

The varizig market covered in this report is segmented –
1) By Patient Condition: Immunocompromised Patients; Pregnant Women
2) By Distribution Channel: Hospitals; Pharmacies; Healthcare Providers
3) By End User: Adult; Geriatric; Pediatric For further insights on the VariZIG market, request a sample here

Which region has the largest share of the VariZIG market? What are the other regions covered in the report?

North America was the largest region in the varizig market in 2024. The regions covered in the varizig market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the VariZIG market, request a sample here.

Who are the major players in the VariZIG market?

Major companies operating in the varizig market are Emergent BioSolutions Inc. . For further insights on the VariZIG market, request a sample here.

What are the key trends in the VariZIG market?

Major trends in the VariZIG market include Strategic Agreement To Gain Competitive Advantage In The Market. For further insights on the VariZIG market, request a sample here.

What are the major opportunities in the VariZIG market? What are the strategies for the VariZIG market?

For detailed insights on the major opportunities and strategies in the VariZIG market, request a sample here.

How does the VariZIG market relate to the overall economy and other similar markets?

For detailed insights on VariZIG's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the VariZIG industry?

For detailed insights on the mergers and acquisitions in the VariZIG industry, request a sample here.

What are the key dynamics influencing the VariZIG market growth? SWOT analysis of the VariZIG market.

For detailed insights on the key dynamics influencing the VariZIG market growth and SWOT analysis of the VariZIG industry, request a sample here.